Angiodysplasia (angioectasia) is an acquired degenerative vascular malformation of dilated, tortuous mucosal/submucosal vessels — the most common vascular lesion of the GI tract and a leading cause of chronic/recurrent LGIB in patients >60 years old. [1-2] It accounts for 3–40% of LGIB and 35–50% of small bowel bleeding. [2] Bleeding is typically painless, often self-limiting, but recurrent — with a pooled recurrence risk of ~34%. [3]
The following figure from Alali et al. outlines the initial evaluation and management algorithm for acute LGIB, including angioectasia-specific therapeutic pathways:
1. History
- Character of bleeding: painless hematochezia (bright red or maroon), melena, or occult blood loss discovered on workup for iron deficiency anemia [1-2]
- Timing: episodic, intermittent, often chronic/recurrent; ask about prior episodes and prior colonoscopies
- Volume and frequency: number of bloody bowel movements, clots, blood on tissue vs. in bowl
- Associated symptoms: fatigue, dyspnea on exertion, lightheadedness (symptoms of anemia); notably absence of abdominal pain distinguishes from ischemic colitis and IBD [1]
- Medication history: anticoagulants, antiplatelets (especially aspirin, clopidogrel), NSAIDs — these significantly increase risk of overt bleeding [1][3]
- Prior GI bleeding episodes, prior endoscopic treatments, transfusion history
- History of aortic stenosis (Heyde syndrome), end-stage renal disease, von Willebrand disease [1-2]
- Recent polypectomy (to exclude postpolypectomy bleeding)
2. Alarm Features
- Hemodynamic instability: tachycardia, hypotension, orthostasis, shock index ≥1 [4-5]
- Large-volume hematochezia with clots
- Syncope or presyncope
- Hemoglobin drop >2 g/dL from baseline or Hgb <7 g/dL
- Ongoing transfusion requirement (≥2 units PRBC in 24 hours) [3]
- Signs of end-organ hypoperfusion (altered mental status, chest pain, oliguria)
- Anticoagulated patient with uncontrolled bleeding
- Concern for upper GI source masquerading as LGIB (hematemesis, coffee-ground emesis, melena with epigastric pain) [3]
3. Medications
- Contributors to bleeding: Anticoagulants (warfarin, DOACs), antiplatelets (aspirin, clopidogrel, ticagrelor), NSAIDs — advanced age + anticoagulant use significantly increases risk of active bleeding from angiodysplasia [1][3]
- Acute management: Consider anticoagulation reversal if life-threatening bleeding (vitamin K, 4-factor PCC for warfarin; idarucizumab for dabigatran; andexanet alfa for factor Xa inhibitors) [5]
- Pharmacologic adjuncts for refractory/recurrent bleeding:
- Octreotide LAR 10–30 mg IM q28 days — first-line pharmacologic therapy for transfusion-dependent recurrent angiodysplasia bleeding refractory to endoscopic therapy; 82% reduction in transfusion requirements, 83% of patients achieve ≥50% reduction in bleeding episodes [6-7]
- Thalidomide 50–100 mg/day — effective antiangiogenic agent but reserved for refractory cases due to significant adverse effects (peripheral neuropathy, constipation, teratogenicity); dose-dependent reduction in rebleeding at 1 year [8-9]
- Hormonal therapy (estrogen-progesterone) — no longer recommended due to lack of efficacy [10-11]
- Iron supplementation: Oral or IV iron for iron deficiency anemia; IV iron preferred in severe depletion or intolerance of oral [8]
4. Diet
- No specific dietary triggers for angiodysplasia
- Ensure adequate iron-rich foods (red meat, leafy greens, fortified cereals) for chronic anemia management
- Maintain hydration, especially during acute bleeding episodes
- Avoid alcohol excess (contributes to coagulopathy and liver disease, which worsens outcomes) [1]
5. Review of Systems
- GI: Stool color/consistency, frequency, abdominal pain (absence favors angiodysplasia over ischemic colitis), weight loss (raises concern for malignancy), change in bowel habits
- Cardiovascular: Exertional dyspnea, chest pain, known murmur or aortic stenosis (Heyde syndrome) [1]
- Hematologic: Easy bruising, petechiae, known bleeding diathesis (von Willebrand disease) [2]
- Renal: Dialysis status, uremia (ESRD associated with angiodysplasia) [2]
- Constitutional: Fatigue, exercise intolerance (chronic anemia)
6. Collateral History and Family History
- Collateral: Confirm medication list (especially anticoagulants/antiplatelets), baseline functional status, prior colonoscopy findings, transfusion history
- Family history: Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu) — autosomal dominant, causes mucocutaneous and visceral telangiectasias [2]
- Von Willebrand disease (acquired or hereditary) [2]
- Family history of colorectal cancer (to consider malignancy in differential)
7. Risk Factors
- Age >60 years — strongest risk factor; age-related vessel degeneration [1-2]
- Aortic stenosis (Heyde syndrome) — acquired von Willebrand factor deficiency (loss of high-molecular-weight multimers) promotes bleeding from angiodysplasia [1]
- End-stage renal disease / chronic kidney disease [2]
- Von Willebrand disease (acquired or hereditary) [2]
- Anticoagulant and antiplatelet therapy [3][12]
- Type 2 diabetes mellitus [12]
- Prior pelvic radiation [12]
- Liver disease (associated with poor outcomes) [1]
- Cardiovascular and pulmonary comorbidities [1]
8. Differential Diagnosis
9. Past Medical History
- Prior episodes of GI bleeding and prior endoscopic interventions (APC, clipping)
- Known angiodysplasia on prior colonoscopy
- Aortic stenosis or prior aortic valve replacement (Heyde syndrome resolves after valve replacement) [7]
- Chronic kidney disease / dialysis
- Von Willebrand disease
- Liver disease / cirrhosis
- Anticoagulation indication (atrial fibrillation, VTE, mechanical valve)
- Prior abdominal/pelvic surgery or radiation
10. Physical Exam
- Vitals: Heart rate, blood pressure (orthostatics), shock index (HR/SBP — ≥1 suggests hemodynamic instability) [4]
- General: Pallor, diaphoresis, altered mental status
- Cardiovascular: Systolic crescendo-decrescendo murmur (aortic stenosis — Heyde syndrome); signs of heart failure [1]
- Abdominal: Typically non-tender (pain suggests ischemic colitis, IBD, or other etiology); assess for hepatosplenomegaly, stigmata of liver disease [3]
- Rectal exam: Stool color (bright red, maroon, melena), hemorrhoids, masses; rule out anorectal source [3]
- Skin: Telangiectasias on lips/oral mucosa/fingers (hereditary hemorrhagic telangiectasia); pallor of conjunctivae/nail beds; petechiae/ecchymoses (coagulopathy)
11. Lab Studies
- CBC: Hemoglobin/hematocrit (baseline and serial), platelet count — microcytic anemia suggests chronic blood loss [1]
- Type and screen / crossmatch: For potential transfusion
- BMP: BUN/creatinine — elevated BUN:Cr ratio may suggest upper GI source; assess renal function
- Coagulation studies: PT/INR, aPTT — especially if on anticoagulants
- Iron studies: Ferritin, serum iron, TIBC — iron deficiency anemia is the hallmark of chronic angiodysplasia bleeding [3][8]
- Lactate: If concern for hemodynamic compromise or ischemia
- LFTs: Assess for liver disease (risk factor for poor outcomes)
- Transfusion threshold: Hgb <7 g/dL (or <8 g/dL with myocardial ischemia) per ACG guidelines [5]
12. Imaging
- CT angiography (CTA) of abdomen/pelvis:
- First-line in hemodynamically unstable patients or those with suspected active bleeding; sensitivity ~90% for identifying bleeding source [16-17]
- Multiphase technique (non-contrast, arterial, venous phases); look for contrast extravasation [17]
- ~80% of patients with negative CTA will have no rebleeding [16]
- Not indicated as first-line in stable patients where bleeding has subsided [17]
- Colonoscopy: Preferred diagnostic/therapeutic modality in hemodynamically stable patients after bowel preparation [13][16]
- Catheter angiography: Reserved for patients with positive CTA who are candidates for embolization, or when colonoscopy fails [18]
- Capsule endoscopy: For suspected small bowel angiodysplasia when upper and lower endoscopy are non-diagnostic [18]
- Tc-99m RBC scintigraphy: Not routinely recommended; may detect intermittent bleeding at lower rates than CTA [13]
13. Special Tests
- Oakland Score: Risk stratification for LGIB; score ≤8 may allow safe outpatient management [3-4]
- NOBLADS Score: Predicts severe bleeding (AUROC 0.77); incorporates NSAID use, no diarrhea, no abdominal tenderness, blood loss, antiplatelet use, disease score, sex [3]
- Shock Index (HR/SBP): ≥1 indicates hemodynamic instability and need for urgent intervention [4]
- Echocardiography: If aortic stenosis suspected (Heyde syndrome) — aortic valve replacement can resolve bleeding [1][7]
- Von Willebrand factor panel: If clinical suspicion (especially with aortic stenosis — acquired vWD) [2]
14. ECG
- Obtain ECG in all patients with significant anemia or hemodynamic instability
- Assess for demand ischemia (ST changes, T-wave inversions) secondary to anemia
- Arrhythmias (atrial fibrillation — relevant for anticoagulation decisions)
- Tachycardia as a marker of hypovolemia
- Note: One case report documented ventricular tachycardia during colonoscopy in an elderly patient with angiodysplasia and cardiac comorbidities [19]
15. Assessment
Angiodysplasia is an acquired, degenerative vascular malformation predominantly affecting elderly patients, most commonly located in the cecum and ascending colon. [1] Key clinical features:
- Typically presents as painless, intermittent bleeding — ranging from occult iron deficiency anemia to overt hematochezia [1][3]
- Majority of episodes are self-limiting but recurrence is common (~34%) [3]
- Lesions appear on colonoscopy as flat, red ectatic blood vessels radiating from a central feeding vessel, typically <10 mm [1-2]
- 40–60% of patients have multiple lesions; ~20% have synchronous lesions in other GI segments [2]
- Severity ranges from chronically well-compensated (majority) to acutely life-threatening (minority) [2]
- Complications: recurrent bleeding, transfusion dependence, iron deficiency anemia, hemodynamic instability
16. Treatment Plan
Initial stabilization
- ABCs, two large-bore IVs, crystalloid resuscitation
- Transfuse PRBCs for Hgb <7 g/dL (or <8 g/dL with cardiac ischemia); use restrictive strategy [5]
- Reverse anticoagulation if life-threatening bleeding [5]
Endoscopic therapy (first-line for identified lesions)
- Argon plasma coagulation (APC) — treatment of choice; flow rate 0.8–1.0 L/min, power 20–40 W; excellent safety profile [3][15]
- For large right-sided lesions: submucosal injection before APC to reduce perforation risk [3]
- Clipping for refractory bleeding [3]
- Tattoo or clip adjacent to treated lesion for relocalization if rebleeding [15]
Interventional radiology
- Transcatheter arterial embolization (TAE) — for patients with positive CTA who fail endoscopic therapy or are hemodynamically unstable [1][18]
- Superselective microcoil or glue embolization of vasa recta [17]
Pharmacologic therapy (for recurrent/refractory bleeding)
- Octreotide LAR 10–30 mg IM q28 days — first-line pharmacologic adjunct; evaluate response at 6 months; can be continued for years if effective [6]
- Thalidomide 50–100 mg/day — reserve for failure of all other therapies due to adverse effects (neuropathy, teratogenicity) [8-9]
- Iron replacement (oral or IV) for all patients with iron deficiency [8]
Surgical resection
Heyde syndrome
- Aortic valve replacement[7]
17. Disposition
- Admit if: hemodynamic instability, active ongoing bleeding, Hgb <7 g/dL, need for transfusion, anticoagulated with significant bleeding, significant comorbidities, Oakland score >8 [3-4]
- ICU/monitored bed if: shock index ≥1, requiring vasopressors, massive transfusion, or active hemorrhage requiring urgent intervention [5]
- Observation if: bleeding has ceased but concern for recurrence, borderline hemoglobin, need for inpatient colonoscopy
- Discharge with outpatient follow-up may be appropriate if: Oakland score ≤8, hemodynamically stable, bleeding has stopped, hemoglobin stable, reliable follow-up available [4][16]
- GI consultation: All patients with suspected angiodysplasia for colonoscopy planning
- Interventional radiology consultation: If CTA positive or endoscopic therapy fails [18]
- Cardiology/cardiac surgery: If aortic stenosis identified (Heyde syndrome evaluation) [7]
18. Follow Up / Return Precautions
- Follow-up: GI within 1–2 weeks if discharged; sooner if recurrent symptoms
- Return immediately for: recurrent hematochezia or melena, lightheadedness/syncope, chest pain, shortness of breath, passage of large clots
- Counsel patients: Bleeding from angiodysplasia is recurrent in ~1 in 3 patients — this is expected and does not necessarily indicate treatment failure [3]
- Monitor serial hemoglobin and iron studies in outpatient setting
- Continue iron supplementation until stores are replete
- Discuss anticoagulation management with prescribing physician — weigh bleeding risk vs. thromboembolic risk
- If on octreotide LAR, reassess at 6 months for transfusion reduction and hemoglobin improvement [6]
- Expected course: Most episodes self-resolve, but chronic management is often required for recurrent bleeding [2]
References
1. Gastrointestinal Surgical Emergencies Textbook. — Ashley E. Aaron, Andrea Amabile, Ciro Andolfi, et al American College of Surgeons (2021). 2021.
2. Endoscopic Therapy for Gastrointestinal Angiodysplasia. — Alhamid A, Aljarad Z, Chaar A, Grimshaw A, Hanafi I. The Cochrane Database of Systematic Reviews. 2024.
3. Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline. — Sengupta N, Feuerstein JD, Jairath V, et al. The American Journal of Gastroenterology. 2023.
4. Review article: Advances in the management of lower gastrointestinal bleeding. — Alali AA, Almadi MA, Barkun AN. Alimentary Pharmacology & Therapeutics. 2024.
5. Emergency Medicine Updates: Lower Gastrointestinal Bleeding. — Long B, Gottlieb M. The American Journal of Emergency Medicine. 2024.
6. Effectiveness and Predictors of Response to Somatostatin Analogues in Patients With Gastrointestinal Angiodysplasias: A Systematic Review and Individual Patient Data Meta-Analysis. — Goltstein LCMJ, Grooteman KV, Rocco A, et al. The Lancet. Gastroenterology & Hepatology. 2021.
7. Recent Advances in the Treatment of Refractory Gastrointestinal Angiodysplasia. — Becq A, Sidhu R, Goltstein LCMJ, Dray X. United European Gastroenterology Journal. 2024.
8. AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review. — DeLoughery TG, Jackson CS, Ko CW, Rockey DC. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association. 2024.
9. Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia. — Chen H, Wu S, Tang M, et al. The New England Journal of Medicine. 2023.
10. Pharmacological Therapy for Gastrointestinal Angiodysplasia. — Tinoco Magalhães R, Valadas R, Cipriano P, Cruz D. Medicina Clinica. 2026.
11. The Role of Endoscopy in the Management of Suspected Small-Bowel Bleeding. — Gurudu SR, Bruining DH, Acosta RD, et al. Gastrointestinal Endoscopy. 2017.
12. Colonoscopic and Clinical Features of Colonic Angiodysplasia: A Study in 54 Patients. — Zhang C, Wang Y, Zhang D, Li S. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. 2023.
13. Acute Lower Gastrointestinal Bleeding: Evaluation and Management. — Hawks MK, Svarverud JE. American Family Physician. 2020.
14. The Role of Endoscopy in the Patient With Lower GI Bleeding. — Pasha SF, Shergill A, Acosta RD, et al. Gastrointestinal Endoscopy. 2014.
15. Acute Lower Gastrointestinal Bleeding. — Gralnek IM, Neeman Z, Strate LL. The New England Journal of Medicine. 2017.
16. Management of Acute Lower GI Bleeding: Guidelines From the American College of Gastroenterology. — Hawks MK. American Family Physician. 2024.
17. The Role of Imaging for Gastrointestinal Bleeding: Consensus Recommendations From the American College of Gastroenterology and Society of Abdominal Radiology. — Sengupta N, Kastenberg DM, Bruining DH, et al. The American Journal of Gastroenterology. 2024.
18. ACR Appropriateness Criteria® Radiologic Management of Lower Gastrointestinal Tract Bleeding: 2021 Update. — Karuppasamy K, Kapoor BS, Fidelman N, et al. Journal of the American College of Radiology : JACR. 2021.
19. Contrast-Enhanced Computed Tomography Assisted Diagnosis of Bleeding Caused by Colonic Angiodysplasia: A Case Report. — Chen Y, Liu X, Guo L, Tang Y, Meng X. Medicine. 2024.